BIOMAT Database Logo BIOMAT Database Logo

Further studies on long-term contraception by subcutaneous silastic R capsules containing megestrol acetate. 1972

E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum

UI MeSH Term Description Entries
D008535 Megestrol A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer. 17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione,Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-
D008599 Menstruation Disturbances Variations of MENSTRUATION which may be indicative of disease. Hypomenorrhea,Menstruation Disorders,Menstruation, Retrograde,Polymenorrhea,Irregular Menses,Irregular Menstruation,Menstrual Irregularities,Menstrual Irregularity,Disorder, Menstruation,Disorders, Menstruation,Disturbance, Menstruation,Disturbances, Menstruation,Irregularity, Menstrual,Menses, Irregular,Menstruation Disorder,Menstruation Disturbance,Menstruation, Irregular,Retrograde Menstruation
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D003270 Contraceptive Agents Chemical substances that prevent or reduce the probability of CONCEPTION. Contraceptive,Contraceptive Effect,Contraceptive Effects,Contraceptives,Agents, Contraceptive,Effect, Contraceptive,Effects, Contraceptive
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Use of subcutaneous Silastic capsules for long-term steroid contraception.
July 1970, American journal of obstetrics and gynecology,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Long-term contraception by steroid releasing implants. III. Mode of action of megestrol acetate (MA) administered by subcutaneous silastic implants in women.
November 1975, The Indian journal of medical research,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Long-term contraception with norethindrone subcutaneous capsules.
April 1976, Annals of clinical research,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women.
May 1975, Contraception,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Long-term contraception by a single silastic implant-D containing norethindrone acetate in women: a clinical evaluation.
April 1978, Contraception,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsules.
December 1969, American journal of obstetrics and gynecology,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Eighteen months contraception following subdermal insertion of silastic capsules containing norgestrienone.
January 1978, International journal of fertility,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Liver studies during oral contraception with low doses of megestrol acetate.
January 1972, International journal of fertility,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Further clinical studies with megestrol acetate in advanced breast cancer.
July 1976, Cancer,
E M Coutinho, and C E Mattos, and A R Sant'Anna, and J A Filho, and M C Silva, and H J Tatum
Contraception with megestrol acetate implants. Megestrol acetate levels in plasma and the influence on the ovarian function.
June 1976, Contraception,
Copied contents to your clipboard!